Skip to main content

Bispecific EGFR- and MET-Directed Antibodies

Bispecific EGFR- and MET-directed antibodies are used to treat certain types of lung cancer. They work by blocking EGFR and MET proteins to slow cancer growth.

Why are bispecific egfr and met directed antibodies prescribed?

  1. Lung Cancer (100%)
Prices for popular Bispecific EGFR- and MET-Directed Antibodies medications
Viewing 2 of 2 medications
vial icon

Rybrevant

AMIVANTAMAB treats lung cancer. It works by helping your immune system slow or stop the spread of cancer cells. It is a monoclonal antibody.
See pricesMore info
vial icon

Rybrevant Faspro

Rybrevant Faspro is only available as a brand name drug.
See pricesMore info
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Compare other Bispecific EGFR- and MET-Directed Antibodies drugs

Rybrevant vs TagrissoImfinzi vs KeytrudaJemperli vs KeytrudaKeytruda vs OpdivoKeytruda vs Tecentriq

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.
ABCDFGHIJKLMNOPQRSTUVWXYZ